Is now the time to buy infrastructure trusts?

Focus on alternative sector

clock • 2 min read

In a seemingly more politicised and less certain world, investors are being forced to revisit areas they may have previously steered away from.

One such space is infrastructure - or more specifically, listed infrastructure vehicles (vehicles that directly own tangible assets and projects, such as HICL Infrastructure and John Laing Infrastructure). These are different from listed companies that operate within the infrastructure arena, such as Vodafone, Centrica or Ferrovial in Spain. Investors' concerns started with John McDonnell's Labour Party conference speech last September when he declared a Labour government would "bring existing PFI contracts back in-house". Uncertainty grew with the failure of Carillion and a profit...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot